Armistice Capital, LLC Rani Therapeutics Holdings, Inc. Transaction History
Armistice Capital, LLC
- $6.02 Billion
- Q3 2024
A detailed history of Armistice Capital, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Armistice Capital, LLC holds 2,574,000 shares of RANI stock, worth $6.36 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,574,000Holding current value
$6.36 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
37Shares Held
3.09MCall Options Held
2KPut Options Held
3.1K-
Vanguard Group Inc Valley Forge, PA710KShares$1.75 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$1.22 Million1.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$1.11 Million0.07% of portfolio
-
United Services Automobile Association San Antonio, TX312KShares$770,8740.03% of portfolio
-
Stifel Financial Corp St. Louis, MO270KShares$666,3260.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $60.5M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...